Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer.

Huynh, Hung

Bevacizumab and rapamycin inhibit tumor growth in peritoneal model of human ovarian cancer. [electronic resource] - Molecular cancer therapeutics Nov 2007 - 2959-66 p. digital

Publication Type: Journal Article; Research Support, Non-U.S. Gov't

1535-7163

10.1158/1535-7163.MCT-07-0237 doi


Animals
Antibodies, Monoclonal--pharmacology
Antibodies, Monoclonal, Humanized
Antineoplastic Agents--pharmacology
Ascites--pathology
Bevacizumab
Body Weight--drug effects
Cell Line, Tumor
Cell Proliferation--drug effects
Disease Models, Animal
Female
Humans
Mice
Mice, SCID
Neoplasm Proteins--metabolism
Ovarian Neoplasms--pathology
Peritoneal Neoplasms--pathology
Sirolimus--pharmacology
Tumor Burden--drug effects